The Impact of Cigarillo Warnings on Purchasing

The Impact of Cigarillo Warnings on Purchasing Behaviors Among Young Adult Cigarillo Users

NCT05434013•Boston University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Cigar Smoking

Interventions

Cigarillo warnings-Surgeon General Text-Only

Cigarillo warnings-FDA proposed text-only

+1 more

Locations

United States

Locations (1)

Wake Forest University Health Sciences

Winston-Salem, North Carolina, United States

Key Dates

Start Date

June 24, 2022

Primary Completion Date

July 21, 2022

Completion Date

July 21, 2022

Last Updated

August 2, 2023

Sponsors

Lead Sponsor

Boston University

Collaborators

Brown University
National Institutes of Health (NIH)
Food and Drug Administration (FDA)
National Cancer Institute (NCI)
Wake Forest University Health Sciences

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 2, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions